July 14 – Guangdong By-health Biotechnology (RCode:300146) predicts that net profits for first half of 2011 will hit between 81.73 million and 92.62 million yuan, up 50 and 70 percent year-on-year, reports Southern Metropolis Daily, citing a company filing.

It is reported that 70 percent of sales growth came from the rapid expansion of outlets which rose from 13,000 units at the end of 2010 to the current 16,000 units.